Cme (CME) Price to Sales (2009 - 2026)

Cme (CME) has reported Price to Sales for 18 consecutive years, with 46.5 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 20.63% year-over-year to 46.5 in Q2 2026; TTM through Jun 2026 was 11.71, a 23.85% decrease from a year earlier, with the FY2025 full-year figure at 15.03, up 10.35% from the prior year.
• Price to Sales was 46.5 for Q2 2026 at Cme, down from 56.83 in the prior quarter.
• Over five years, Price to Sales peaked at 63.35 in Q1 2022 and troughed at 46.1 in Q2 2024.
• A 5-year average of 54.05 and a median of 53.16 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales sank 30.02% in 2022 and gained 27.08% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 49.97 in 2022, then rose by 5.18% to 52.56 in 2023, then gained by 4.16% to 54.75 in 2024, then rose by 8.59% to 59.45 in 2025, then fell by 21.79% to 46.5 in 2026.
• The last three Price to Sales figures came in at 46.5 (Q2 2026), 56.83 (Q1 2026), and 59.45 (Q4 2025), per Business Quant data.